MedTrace Logo

Assessment of the Acute Effect of IP

NCT03658187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-05-31

No results posted yet for this study

Summary

It is a nutraceutical system, consisting of oral tablet and an oral spray called Alpha GPC, which helps your body naturally restore the HGH levels.

Conditions

  • Deficiency Growth Hormone

Interventions

DIETARY_SUPPLEMENT

Placebo

Beige-brown powder with speckles in clear enteric coated caplet with berry flavor liquid.

DIETARY_SUPPLEMENT

IP

Beige-brown powder with speckles in clear enteric coated caplet with berry flavor liquid.

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Shalini Srivastava, M.D. · Vedic Lifesciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-19
Primary Completion
2018-10-25
Completion
2019-01-25

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658187 on ClinicalTrials.gov